In Vitro Glucose Uptake, α-Amylase, Antioxidant and Cytotoxic Evaluation of Dalbergiella Welwitschii as a Potential Glucose-Lowering Agent for Type 2 Diabetes

Hyperglycemia is a major complication of type 2 diabetes. Medicinal plants could mitigate this complication due to their bioactive phytochemicals. Dalbergiella welwitschii is a plant used traditionally to manage hyperglycemia in Nigeria. This study explores the glucose-lowering potential of different parts of Dalbergiella welwitschii through in vitro glucose uptake and α-amylase inhibitory assays alongside antioxidant and phytochemical screening. The glucose uptake activity was evaluated using yeast cells (Saccharomyces cerevisiae) at glucose concentrations of 25, 10 and 5 mM, and extract concentrations of 1000, 500 and 250 µg/mL, respectively. α-Amylase inhibitory activity was determined using the 3,5-dinitosalicyclic acid (DNSA) method. Antioxidant activity was assessed using the DPPH radical scavenging assay and cytotoxicity was evaluated using the brine shrimp lethality assay. Stem extract of Dalbergiella welwitschii exhibited percentage glucose uptake of 92.20 ± 0.16, 96.70 ± 0.00, 85.40 ± 0.17 comparable to the standard Glimepiride-metformin-HCl (92.23 ± 0.06, 91.30 ± 0.10, 88.47 ± 0.42) at 10 mM glucose concentration. The leaf, stem and root had moderate α-amylase inhibitory activity (289.8 ± 0.03, 150.6 ± 0.03, 263.1 ± 0.03 µg/mL) compared with acarbose (33.2 ± 0.00 µg/mL). Phytochemical screening revealed the presence of alkaloids, flavonoids and phenols across all plant parts with higher concentrations in the leaves. The stem extract (0.403 µg/mL) exhibited strong antioxidant activity comparable to ascorbic acid (0.474 µg/mL) and butylated hydroxyanisole (0.315 µg/mL). Brine shrimp lethality assay indicated relatively low cytotoxicity for the extracts compared with the standard cyclophosphamide. These findings indicate that Dalbergiella welwitschii possesses promising glucose-lowering properties through a mechanism involving enhanced glucose utilization, moderate carbohydrate digestion and antioxidant activity supporting its potential for further pharmacological investigation.

Authors

Institutions

Publication Details

Journal
Journal of Medicinal Natural Products
Published
2026-08-27
DOI
https://doi.org/10.53941/jmnp.2026.100016
Primary Topic
Natural Antidiabetic Agents Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

In Vitro Glucose Uptake, α-Amylase, Antioxidant and Cytotoxic Evaluation of Dalbergiella Welwitschii as a Potential Glucose-Lowering Agent for Type 2 Diabetes

Ufuoma Modupe Oghenejoboh, Olusegun Ekundayo, Oluwadayo O. Sonibare, Mukaram A. Adeniyi-Akee
Journal of Medicinal Natural Products
Natural Antidiabetic Agents Studies
article

In Vitro Glucose Uptake, α-Amylase, Antioxidant and Cytotoxic Evaluation of Dalbergiella Welwitschii as a Potential Glucose-Lowering Agent for Type 2 Diabetes

Ufuoma Modupe Oghenejoboh, Olusegun Ekundayo, Oluwadayo O. Sonibare, Mukaram A. Adeniyi-Akee
article en

Abstract

Hyperglycemia is a major complication of type 2 diabetes. Medicinal plants could mitigate this complication due to their bioactive phytochemicals. Dalbergiella welwitschii is a plant used traditionally to manage hyperglycemia in Nigeria. This study explores the glucose-lowering potential of different parts of Dalbergiella welwitschii through in vitro glucose uptake and α-amylase inhibitory assays alongside antioxidant and phytochemical screening. The glucose uptake activity was evaluated using yeast cells (Saccharomyces cerevisiae) at glucose concentrations of 25, 10 and 5 mM, and extract concentrations of 1000, 500 and 250 µg/mL, respectively. α-Amylase inhibitory activity was determined using the 3,5-dinitosalicyclic acid (DNSA) method. Antioxidant activity was assessed using the DPPH radical scavenging assay and cytotoxicity was evaluated using the brine shrimp lethality assay. Stem extract of Dalbergiella welwitschii exhibited percentage glucose uptake of 92.20 ± 0.16, 96.70 ± 0.00, 85.40 ± 0.17 comparable to the standard Glimepiride-metformin-HCl (92.23 ± 0.06, 91.30 ± 0.10, 88.47 ± 0.42) at 10 mM glucose concentration. The leaf, stem and root had moderate α-amylase inhibitory activity (289.8 ± 0.03, 150.6 ± 0.03, 263.1 ± 0.03 µg/mL) compared with acarbose (33.2 ± 0.00 µg/mL). Phytochemical screening revealed the presence of alkaloids, flavonoids and phenols across all plant parts with higher concentrations in the leaves. The stem extract (0.403 µg/mL) exhibited strong antioxidant activity comparable to ascorbic acid (0.474 µg/mL) and butylated hydroxyanisole (0.315 µg/mL). Brine shrimp lethality assay indicated relatively low cytotoxicity for the extracts compared with the standard cyclophosphamide. These findings indicate that Dalbergiella welwitschii possesses promising glucose-lowering properties through a mechanism involving enhanced glucose utilization, moderate carbohydrate digestion and antioxidant activity supporting its potential for further pharmacological investigation.

Journal of Medicinal Natural ProductsVol. 3(3)
University of Ibadan (NG), Delta State University (NG), Igbinedion University (NG)
Openalex Percentile: Top 11%
Natural Antidiabetic Agents Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.